Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 6 studies | 25% ± 6% | |
epithelial cell | 3 studies | 20% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 24% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 699.81 | 459 / 459 | 100% | 6.30 | 1118 / 1118 |
esophagus | 100% | 525.45 | 1445 / 1445 | 100% | 5.91 | 183 / 183 |
ovary | 100% | 811.43 | 180 / 180 | 100% | 7.08 | 430 / 430 |
prostate | 100% | 719.82 | 245 / 245 | 100% | 6.23 | 502 / 502 |
skin | 100% | 917.61 | 1809 / 1809 | 100% | 5.97 | 471 / 472 |
brain | 100% | 658.17 | 2639 / 2642 | 100% | 6.15 | 704 / 705 |
thymus | 100% | 856.64 | 653 / 653 | 100% | 5.97 | 603 / 605 |
intestine | 100% | 555.09 | 965 / 966 | 99% | 4.61 | 524 / 527 |
bladder | 100% | 628.43 | 21 / 21 | 99% | 5.03 | 500 / 504 |
kidney | 100% | 649.35 | 89 / 89 | 99% | 5.38 | 893 / 901 |
stomach | 99% | 442.07 | 357 / 359 | 99% | 4.41 | 284 / 286 |
pancreas | 100% | 405.72 | 327 / 328 | 99% | 4.59 | 176 / 178 |
uterus | 100% | 845.97 | 170 / 170 | 98% | 5.33 | 452 / 459 |
adrenal gland | 100% | 780.76 | 258 / 258 | 97% | 5.47 | 224 / 230 |
lung | 97% | 558.66 | 561 / 578 | 100% | 6.50 | 1154 / 1155 |
liver | 99% | 264.15 | 223 / 226 | 80% | 1.76 | 323 / 406 |
adipose | 100% | 642.46 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 4.49 | 29 / 29 |
spleen | 100% | 726.71 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 5.10 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.61 | 1 / 1 |
blood vessel | 100% | 537.59 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 398.75 | 851 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 3.43 | 78 / 80 |
muscle | 96% | 269.33 | 768 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 76% | 326.93 | 710 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006974 | Biological process | DNA damage response |
GO_0006281 | Biological process | DNA repair |
GO_0009267 | Biological process | cellular response to starvation |
GO_0061014 | Biological process | positive regulation of mRNA catabolic process |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005739 | Cellular component | mitochondrion |
GO_0043022 | Molecular function | ribosome binding |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | TTC5 |
Protein name | Tetratricopeptide repeat domain 5 Tetratricopeptide repeat protein 5 (TPR repeat protein 5) (Stress-responsive activator of p300) (Protein Strap) |
Synonyms | |
Description | FUNCTION: Cofactor involved in the regulation of various cellular mechanisms such as actin regulation, autophagy, chromatin regulation and DNA repair . In non-stress conditions, interacts with cofactor JMY in the cytoplasm which prevents JMY's actin nucleation activity and ability to activate the Arp2/3 complex. Acts as a negative regulator of nutrient stress-induced autophagy by preventing JMY's interaction with MAP1LC3B, thereby preventing autophagosome formation (By similarity). Involves in tubulin autoregulation by promoting its degradation in response to excess soluble tubulin . To do so, associates with the active ribosome near the ribosome exit tunnel and with nascent tubulin polypeptides early during their translation, triggering tubulin mRNA-targeted degradation . Following DNA damage, phosphorylated by DNA damage responsive protein kinases ATM and CHEK2, leading to its nuclear accumulation and stability. Nuclear TTC5/STRAP promotes the assembly of a stress-responsive p53/TP53 coactivator complex, which includes the coactivators JMY and p300, thereby increasing p53/TP53-dependent transcription and apoptosis. Also recruits arginine methyltransferase PRMT5 to p53/TP53 when DNA is damaged, allowing PRMT5 to methylate p53/TP53. In DNA stress conditions, also prevents p53/TP53 degradation by E3 ubiquitin ligase MDM2 (By similarity). Upon heat-shock stress, forms a chromatin-associated complex with heat-shock factor 1 HSF1 and p300/EP300 to stimulate heat-shock-responsive transcription, thereby increasing cell survival . Mitochondrial TTC5/STRAP interacts with ATP synthase subunit beta ATP5F1B which decreased ATP synthase activity and lowers mitochondrial ATP production, thereby regulating cellular respiration and mitochondrial-dependent apoptosis. Mitochondrial TTC5/STRAP also regulates p53/TP53-mediated apoptosis (By similarity). . |
Accessions | G3V3I6 ENST00000383029.7 ENST00000708730.1 Q8N0Z6 ENST00000553828.1 ENST00000258821.8 H9KV81 |